A new study is changing the way scientists and clinicians think about stimulant medications used to treat attention-deficit/hyperactivity disorder (ADHD).
For decades, it was widely believed that drugs like Adderall and Ritalin help by directly improving a person’s ability to focus. But recent research shows that their main effect may be quite different.
Rather than sharpening attention directly, these stimulants appear to act on parts of the brain linked to wakefulness and reward. By increasing alertness and motivation, the medications help people stay engaged with tasks they might otherwise find unrewarding or difficult to sustain.
In practice, this can look like improved focus, but it may be a secondary effect of being more awake and interested in what they’re doing.
Brain imaging from a large research cohort revealed that stimulants activate circuits associated with arousal and reward anticipation more than traditional attention systems. This helps explain why people taking these drugs often find it easier to stick with tasks, even if they don’t feel dramatically more attentive in the moment. The findings also suggest that improved sleep patterns, which stimulants can indirectly influence, may be part of why the drugs help some patients manage their symptoms.
This shift in understanding doesn’t mean the medications are ineffective. In many cases, they still improve daily functioning and help people with ADHD engage more consistently with work, school, and other activities. But the new perspective highlights that their benefit may come from enhancing general engagement and motivation rather than directly boosting concentration.
Experts say this insight could lead to better ways of tailoring treatment and a more nuanced discussion about how and why these medications help individuals with ADHD. It also underscores the importance of considering factors like sleep, motivation, and reward processing when evaluating how well a given therapy is working.